The Agenda

HOOKWORMS AND FRIENDS>> Peter Hotez, the director of the Sabin Institute's Human Hookworm Vaccine Initiative, is prominent in Merrill Goozner's feature on the initiative's trials now getting underway in Brazil (see story). He also appears in a new book by Gerald Esch, Parasites and Infectious Disease: Discovery by Serendipity and Otherwise (Cambridge University Press), which comes out this month. INTEREST ON INNOVATION>> In this article, Kerry Grens looks

The Scientist Staff
Jul 1, 2007

HOOKWORMS AND FRIENDS>> Peter Hotez, the director of the Sabin Institute's Human Hookworm Vaccine Initiative, is prominent in Merrill Goozner's feature on the initiative's trials now getting underway in Brazil (see story). He also appears in a new book by Gerald Esch, Parasites and Infectious Disease: Discovery by Serendipity and Otherwise (Cambridge University Press), which comes out this month.

INTEREST ON INNOVATION>> In this article, Kerry Grens looks into whether science pays a return on investment. To learn more about the economic impact of health discoveries and pharmaceutical innovation, attend the 6th World Congress on Health Economics in Copenhagen, July 8-11. For more, visit http://www.healtheconomics.org/congress/2007.

SYSTEMS SPEAKER>> In this article, Edyta Zielinska highlights the unique way the Molecular Sciences Institute in Berkeley, Calif. conducts systems biology research. Hear MSI president Roger Brent speak about his work at the Gordon Research Conference on bioinformatics on July...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?